Advanced search
Publication Cover
Scandinavian Journal of Clinical and Laboratory Investigation Volume 78, 2018 - Issue 3
Submit an article Journal homepage
103
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Characterization of SCCA-IgM as a biomarker of liver disease in an Asian cohort of patients

Hoang Bui HuuUniversity of Medicine and Pharmacy of Ho Chi Minh, Ho Chi Minh City, Vietnam; View further author information
,
Nhuong Ha ThucUniversity of Medicine and Pharmacy of Ho Chi Minh, Ho Chi Minh City, Vietnam; View further author information
,
Hoa Pham Thi LeUniversity of Medicine and Pharmacy of Ho Chi Minh, Ho Chi Minh City, Vietnam; View further author information
,
Thuy Do Thi ThanhUniversity of Medicine and Pharmacy of Ho Chi Minh, Ho Chi Minh City, Vietnam; View further author information
,
An Luong BacUniversity of Medicine and Pharmacy of Ho Chi Minh, Ho Chi Minh City, Vietnam; View further author information
,
Claudio TiribelliCentro Studi Fegato AREA Science Park, Trieste, Italy; View further author information
,
Patrizia PontissoDepartment of Medicine, University of Padua, Padua, Italy; View further author information
,
Andrea GallottaXeptagen S.p.A., VEGA Science Park, Venice, ItalyView further author information
,
Laura PaneghettiXeptagen S.p.A., VEGA Science Park, Venice, ItalyView further author information
&
Giorgio FassinaXeptagen S.p.A., VEGA Science Park, Venice, ItalyCorrespondence[email protected]
View further author information
 show all
Pages 204-210 | Received 19 Sep 2017, Accepted 21 Jan 2018, Published online: 30 Jan 2018

References

  • Stanaway JD, Faxman AD, Naghavi M, et al. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet. 2016;388:1081–1088.
  • World Health Organization. Fact sheet on hepatitis 2016. Available from: http://www.who.int/hepatitis/en/
  • Omata M, Lesmana LA, Tateishi R, et al. Asian Pacific Association for the Study of the Liver consensus recommend`ations on hepatocellular carcinoma. Hepatol Int. 2010;4:439–474.
  • Martini A, Gallotta A, Pontisso P, et al. Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis C. World J Hepatol. 2015;7:2913–2919.
  • Vidalino L, Doria A, Quarta S, et al. SERPINB3, apoptosis and autoimmunity. Autoimmun Rev. 2009;9:108–112.
  • Catanzaro JM, Sheshadri N, Pan JA, et al. Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4. Nat Commun. 2014;5:3729.
  • Kato H. Expression and function of squamous cell carcinoma antigen. Anticancer Res. 1996;16:2149–2154.
  • Pontisso P, Calabrese F, Benvegnù L, et al. Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma. Br J Cancer. 2004;90:833–837.
  • Turato C, Vitale A, Fasolato S, et al. SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis. Br J Cancer. 2014;110:2708–2715.
  • Beneduce L, Castaldi F, Marino M, et al. Squamous cell carcinoma antigen-immunoglobulin M complexes as novel biomarkers for hepatocellular carcinoma. Cancer. 2005;103:2558–2565.
  • Buccione D, Fatti G, Gallotta A, et al. Serum SCCA-IgM as a predictor of hepatocellular carcinoma in patients with cirrhosis. O J Gastroenterol. 2012;2:56–61.
  • Pontisso P, Quarta S, Caberlotto C, et al. Progressive increase of SCCA-IgM immune complexes in cirrhotic patients is associated with development of hepatocellular carcinoma . Int J Cancer. 2006;119:735–740.
  • Pozzan C, Cardin R, Piciocchi M, et al. Diagnostic and prognostic role of SCCA-IgM serum levels in hepatocellular carcinoma (HCC). J Gastroenterol Hepatol. 2014;29:1637–1644.
  • Biasiolo A, Chemello L, Quarta S, et al. Monitoring SCCA-IgM complexes in serum predicts liver disease progression in patients with chronic hepatitis. J Viral Hepat. 2008;15:246–249.
  • Giannini EG, Basso M, Bazzica M, et al. Successful antiviral therapy determines a significant decrease in squamous cell carcinoma antigen-associated (SCCA) variants’ serum levels in anti-HCV positive cirrhotic patients. J Viral Hepat. 2010;17:563–598.
  • Martini A, Fattovich G, Guido M, et al. HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients. J Viral Hepat. 2015;22:800–808.
  • Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2015;10:1–98.
  • Morisco F, Guarino M, Di Costanzo GG, et al. Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in HCC patients. J Hepatol. 2015;62:S450.
  • Biasiolo A, Trotta E, Fasolato S, et al. Squamous cell carcinoma antigen-IgM is associated with hepatocellular carcinoma in patients with cirrhosis: a prospective study. Dig Liver Dis. 2016;48:197–202.
  • Fransvea E, Trerotoli P, Sacco R, et al. SCCA-IC serum levels are predictive of clinical response in HCV chronic hepatitis to antiviral therapy: a multicentric prospective study. J Viral Hepat. 2012;19:704–710.
  • Giannelli G, Fransvea E, Trerotoli P, et al. Clinical validation of combined serological biomarkers for improved hepatocellular carcinoma diagnosis in 961 patients. Clin Chim Acta. 2007;383:147–152.
  • Gish RG, Given BD, Lai C-L, et al. Chronic hepatitis B: virology, natural history, current management and a glimpse at future opportunities. Antiviral Res. 2015;121:47–58.
  • Pearlman BL, Traub N. Sustained virological response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more. Clin Inf Dis. 2011;52:889–900.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.